The balance between memory and regulatory cell populations in kidney transplant recipients with operational tolerance
Clinical and Experimental Immunology · 2024
DOI: 10.1093/cei/uxae018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Immunology, 2024. Verfasst von Caner Süsal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Immunology, University of Heidelberg, Heidelberg, Germany. Hauptthemen laut MEDLINE: Kidney Transplantation, T-Lymphocytes, Regulatory, Immunologic Memory, Memory T Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: European Union's Horizon, European Union’s Horizon.
Abstract (Originalsprache)
Donor-reactive memory cells represent a barrier to long-term kidney graft survival. A better understanding of regulatory mechanisms that counterbalance alloreactive memory responses may help to identify patients with operational tolerance. This prospective study investigated the equilibrium between memory T-cell subsets and regulatory T or B cells (Tregs, Bregs) in peripheral blood of kidney transplant recipients with operational tolerance (N = 8), chronic rejection (N = 8), and different immunosuppressive treatment regimens (N = 81). Patients on hemodialysis and healthy individuals served as controls (N = 50). In addition, the expression of Treg- and Breg-associated molecule genes was analyzed. Patients with chronic rejection showed a disrupted memory T-cell composition with a significantly higher frequency of circulating CD8+ terminally differentiated effector memory (TEMRA) T cells than patients with operational tolerance, patients on hemodialysis, or healthy controls (P < 0.001). Low frequency of CD8+ TEMRA and high frequency of Tregs and transitional Bregs were found in operationally tolerant patients. Consequently, operationally tolerant patients showed, as compared to all other transplant recipients with different immunosuppressive regiments, the lowest ratios between CD8+ TEMRA T cells and Tregs or Bregs (for both P < 0.001). Moreover, a specific peripheral blood transcription pattern was found in operationally tolerant patients with an increased expression of Breg- and Treg-associated genes CD22 and FoxP3 and a decreased FcγRIIA/FcγRIIB transcript ratio (for all P < 0.001). In conclusion, monitoring the balance between circulating CD8+ TEMRA T cells and regulatory cell subsets and their transcripts may help to distinguish transplant recipients with operational tolerance from recipients at risk of graft loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Immunology, University of Heidelberg, Heidelberg, Germany.
- Transplant Immunology Research Center of Excellence, Koç University Hospital, Istanbul, Turkey.
- Grupo de Inmunología Celular e Inmunogenética, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
- Department of Nephrology, University of Heidelberg, Heidelberg, Germany.
ORCID-Profile: Claudius Speer
Förderung
- European Union's Horizon
- European Union’s Horizon
Zitieren
APA
Süsal, C., Alvarez, C. M., Benning, L., Daniel, V., Zeier, M., Schaier, M., Morath, C., & Speer, C. (2024). The balance between memory and regulatory cell populations in kidney transplant recipients with operational tolerance. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxae018
Vancouver
Süsal C, Alvarez CM, Benning L, Daniel V, Zeier M, Schaier M, et al. The balance between memory and regulatory cell populations in kidney transplant recipients with operational tolerance. Clinical and Experimental Immunology. 2024. doi:10.1093/cei/uxae018
BibTeX
@article{Ssal2024,
author = {Süsal, Caner and Alvarez, Cristiam M and Benning, Louise and Daniel, Volker and Zeier, Martin and Schaier, Matthias and Morath, Christian and Speer, Claudius},
title = {The balance between memory and regulatory cell populations in kidney transplant recipients with operational tolerance},
journal = {Clinical and Experimental Immunology},
year = {2024},
doi = {10.1093/cei/uxae018}
}
EUVIMED